Simplex Trading’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Simplex Trading’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-190,300	Closed	-$4.06M	–	10119
2024 Q1	$4.06M	Buy	190,300 +177,600	+1,398%	+$2.12M	﹤0.01%	1764
2023 Q4	$122K	Buy	+12,700	New	+$61.7K	﹤0.01%	5179
2022 Q3	–	Sell	-800	Closed	-$1K	–	11139
2022 Q2	$1K	Sell	800 -100	-11%	-$460	﹤0.01%	9736
2022 Q1	$6K	Hold	900	–	–	﹤0.01%	9346
2021 Q4	$3K	Sell	900 -300	-25%	-$1.87K	﹤0.01%	9904
2021 Q3	$9K	Buy	1,200 +100	+9%	+$842	﹤0.01%	9016
2021 Q2	$8K	Buy	+1,100	New	+$9.47K	﹤0.01%	9255

Simplex Trading's FUSN Position: Q1 2024 in Review

Simplex Trading sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q1 2024, closing a stake of 12,501 shares — an estimated $150K sold.

Simplex Trading first reported a position in FUSN in Q2 2021 and held it in 7 quarters. The position peaked at $120K in Q4 2023. 114 funds tracked by Wall St. Rank hold FUSN as of Q1 2024.

Simplex Trading reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q1 2024 after selling out during the quarter.
Simplex Trading sold 12,501 Fusion Pharmaceuticals Inc. Common Shares shares in Q1 2024, an estimated $150K.
Simplex Trading first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2021 and held it in 7 quarters.
Simplex Trading's Fusion Pharmaceuticals Inc. Common Shares position peaked at $120K in Q4 2023.
114 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.